The safety and efficacy of SGLT2 inhibitors

SLGT2 Inhibitors

Since the SGLT-2 inhibitors have been launched there have been studies that have suggested potential concerns such as ketoacidosis and amputation and those that have demonstrated positive benefits on cardiovascular outcomes. This meta-analysis of the drugs may dispel the anxieties that some primary care clinicians have had over prescribing them.

http://jaha.ahajournals.org/content/7/2/e007165

Share

Related Articles

26th September 2018

Tell Us News Not History!

Research is a very strange thing.  The topics selected by researchers do not seem to have any direction.  They are...

Read More

7th April 2020

Diabetes ahead

Today’s clinical topic is primary care diabetes management which has undergone a sudden transformation in light of...

Read More

6th July 2011

When all’s NSAID and done?

Drugs are having a bad time this year.  The latest batch to come under the hammer are Non-Steroidal Anti-inflammatory...

Read More